Catalogue > Biochemicals > Proteasome-Inhibitors

Proteasome Inhibitors

Biochemicals

Calpain Inhibitor I - Calpain Inhibitor II - Clasto-Lactacystin beta-lactone - Epoxomicin - Lactacystein, min. 95% - MG-132, min. 95.0% - Proteasome Inhibitor I - Proteasome Inhibitor I - Proteasome Inhibitor II - Proteasome Inhibitor MG-115 - Proteasome Inhibitor MG-262


Calpain Inhibitor I 10 mg - S5305.0010
147,21 EUR Package Size: 10 mg protect from light and moisture. Store in tightly sealed vial. Technical Data: white powder; min. 98%; soluble in Ethanol; MW = 383.5 g/mol, C20H37N3O4; CAS: [110044-82-1]. Shipping / Storing Information: shipped at RT, store at +2°C to +8°C Productnumber: S5305.0010 changedate: 6.3.2002



Calpain Inhibitor I 50 mg - S5305.0050
473,19 EUR Package Size: 50 mg protect from light and moisture. Store in tightly sealed vial. Technical Data: white powder; min. 98%; soluble in Ethanol; MW = 383.5 g/mol, C20H37N3O4; CAS: [110044-82-1]. Shipping / Storing Information: shipped at RT, store at +2°C to +8°C Productnumber: S5305.0050 changedate: 6.3.2002



Calpain Inhibitor II 10 mg - S5306.0010
147,21 EUR Package Size: 10 mg Inhibitor of calpain I, calpain II, cathepsin B and cathepsin L. Inhibits activation-induced programmed cell death. Also inhibits the peptidase activity of the 20S proteasome. Protect from light and moisture. Technical Data: white powder, soluble in Ethanol, min. 98%; C19H35N3O4S; MW = 401.6 g/mol;



Calpain Inhibitor II 50 mg - S5306.0050
473,19 EUR Package Size: 50 mg Inhibitor of calpain I, calpain II, cathepsin B and cathepsin L. Inhibits activation-induced programmed cell death. Also inhibits the peptidase activity of the 20S proteasome. Protect from light and moisture. Technical Data: white powder, soluble in Ethanol, min. 98%; C19H35N3O4S; MW = 401.6 g/mol;



Clasto-Lactacystin beta-lactone 200 µg - S5307.0200
540,79 EUR Package Size: 200 µg About 20-fold more potent than lactacystein. Lactacystin is converted to clasto-lactacystin beta-lactone in culture media and in cells where it covalently binds to catalytic subunits of the proteasome. Fenteany, G. et al., Inhibition of proteasome activities and subunit-specific amino-terminal threonine



Epoxomicin 200 µg - S5308.0200
796,16 EUR Package Size: 200 µg Cell permeable, potent, and selective proteasome inhibitor. More potent than Lactocystin. Inhibits the chymotrypsin-like, trypsin-like, and peptidylglutamyl peptide-hydrolyzing activities of the proteasome. Meng L. et al., Epoxomicin, a potent and selective proteasome inhibitor, exhibits in-vivo



Epoxomicin 50 µg - S5308.0050
270,39 EUR Package Size: 50 µg Cell permeable, potent, and selective proteasome inhibitor. More potent than Lactocystin. Inhibits the chymotrypsin-like, trypsin-like, and peptidylglutamyl peptide-hydrolyzing activities of the proteasome. Meng L. et al., Epoxomicin, a potent and selective proteasome inhibitor, exhibits in-vivo



Lactacystein, min. 95% 1 mg - S5313.0001
953,89 EUR Package Size: 1 mg Blocks proteasome activity by targeting the catalytic beta-subunit. Has no effect on serine or cysteine proteases. Comment: Reconstitute in 1mL Water, Methanol or Ethanol. Source: Streptomyces species Technical Data: lyophilised powder, min. 95.0%, C15H24N2O7S; MW = 376,4 g/mol, soluble in water,



Lactacystein, min. 95% 100 µg - S5313.0100
243,35 EUR Package Size: 100 µg Blocks proteasome activity by targeting the catalytic beta-subunit. Has no effect on serine or cysteine proteases. Comment: Reconstitute in 1mL Water, Methanol or Ethanol. Source: Streptomyces species Technical Data: lyophilised powder, min. 95.0%, C15H24N2O7S; MW = 376,4 g/mol, soluble in water,



MG-132, min. 95.0% 1 mg - S5316.0001
96,14 EUR Package Size: 1 mg Potent, reversible and cell permeable proteasome inhibitor. Lee, D.H. and Goldberg A.L., Selective Inhibitors of the Proteasome-Dependent and Vacuolar Pathways of Protein Degradation in Saccharomyces cerevisiae. (1996) 271(44), 27280-27284. pdf



MG-132, min. 95.0% 5 mg - S5316.0005
168,24 EUR Package Size: 5 mg Potent, reversible and cell permeable proteasome inhibitor. Lee, D.H. and Goldberg A.L., Selective Inhibitors of the Proteasome-Dependent and Vacuolar Pathways of Protein Degradation in Saccharomyces cerevisiae. (1996) 271(44), 27280-27284. pdf



Proteasome Inhibitor I 5 mg - S5330.0005
298,93 EUR Package Size: 5 mg Cell-permeable inhibitor of the multicatalytic proteinase complex (MPC, 20S proteasome) in HT4 cells. Causes accumulation of ubiquitinylated proteins in neuronal cells. Source: synthetic Technical Data: min. 95.0%; C32H50N4O8; MW = 618.8 g/mol, soluble in MeOH. Shipping / Storing Information:



Proteasome Inhibitor I 5 x 5 mg - S5330.0025
1.291,88 EUR Package Size: 5 x 5 mg Cell-permeable inhibitor of the multicatalytic proteinase complex (MPC, 20S proteasome) in HT4 cells. Causes accumulation of ubiquitinylated proteins in neuronal cells. Source: synthetic Technical Data: min. 95.0%; C32H50N4O8; MW = 618.8 g/mol, soluble in MeOH. Shipping / Storing Information:



Proteasome Inhibitor II 5 mg - S5331.0005
123,18 EUR Package Size: 5 mg Potent and cell-permeable proteasome inhibitor. Inhibits the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex (MPC, 20S proteasome). Does not inhibit the peptidylglutamyl peptide hydrolyzing activity of the MPC. Source: synthetic Technical Data: min. 95.0%; C29H39N3O5; MW



Proteasome Inhibitor II 5 x 5 mg - S5331.0025
570,83 EUR Package Size: 5 x 5 mg Potent and cell-permeable proteasome inhibitor. Inhibits the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex (MPC, 20S proteasome). Does not inhibit the peptidylglutamyl peptide hydrolyzing activity of the MPC. Source: synthetic Technical Data: min. 95.0%;



Proteasome Inhibitor MG-115 1 mg - S5315.0001
96,14 EUR Package Size: 1 mg Potent, reversible proteasome inhibitor. Lee, D.H. and Goldberg A.L., Selective Inhibitors of the Proteasome-Dependent and Vacuolar Pathways of Protein Degradation in Saccharomyces cerevisiae. (1996) 271(44), 27280-27284. Source: synthetic Technical Data: lyophilised, white powder, min. 99.0%,



Proteasome Inhibitor MG-115 5 mg - S5315.0005
243,35 EUR Package Size: 5 mg Potent, reversible proteasome inhibitor. Lee, D.H. and Goldberg A.L., Selective Inhibitors of the Proteasome-Dependent and Vacuolar Pathways of Protein Degradation in Saccharomyces cerevisiae. (1996) 271(44), 27280-27284. Source: synthetic Technical Data: lyophilised, white powder, min. 99.0%,



Proteasome Inhibitor MG-262 200 µg - S5335.0200
510,74 EUR Package Size: 200 µg Highly potent and selective cell permeable inhibitor of the proteasome. Structurally similar to MG-132 but with much higher potency. Ki=0.023 nM vs. SDS-activated 20S Proteasome. Source: synthetic Technical Data: min. 95.0% (HPLC); MW = 491.44 g/mol; Ki = 0.023 nM; C25H42BN3O6; soluble in DMSO.



Proteasome Inhibitor MG-262 5 x 200 µg - S5335.1000
0,00 EUR Package Size: 5 x 200 µg Highly potent and selective cell permeable inhibitor of the proteasome. Structurally similar to MG-132 but with much higher potency. Ki=0.023 nM vs. SDS-activated 20S Proteasome. Source: synthetic Technical Data: min. 95.0% (HPLC); MW = 491.44 g/mol; Ki = 0.023 nM; C25H42BN3O6; soluble in



Show 1 to 19 (of in total 19 products) Sites:  1